Physician profile
Eran Lev
NPI 1518024678
$19,566.61
in general payments reported to CMS, 2019-2025
12 companies · $4,869 in 2025
The $4,869 reported for 2025 was more than what 84% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $916 · 2020: $38.52 · 2021: $248 · 2022: $3,673 · 2023: $4,942 · 2024: $4,880 · 2025: $4,869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $14K · Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $14,400.00 |
| Food and Beverage | $290.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $18,103.35 | 2019-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Terumo Medical Corporation | $773.13 | 2019 | |
| Boston Scientific Corporation | $181.36 | 2020-2023 | Varithena Administration Pack |
| Misonix INC | $123.06 | 2021 | |
| Becton, Dickinson and Company | $101.73 | 2023-2024 | Venovo, Atlas |
| E.R. Squibb & Sons, L.L.C. | $69.64 | 2022-2023 | Eliquis |
| Aroa Biosurgery Incorporated | $59.32 | 2024-2025 | |
| Smith+Nephew, INC. | $57.57 | 2021-2023 | Collagenase Santyl |
| Pfizer INC. | $35.22 | 2019-2022 | |
| Biocompatibles, INC. | $22.78 | 2019 | |
| Paratek Pharmaceuticals, INC. | $21.88 | 2021 | |
| Tactile Systems Technology INC | $17.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eran Lev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.